Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-11T07:42:45.965Z Has data issue: false hasContentIssue false

Surgical treatment of marked mitral valvar deformity combined with I-cell disease ‘Mucolipidosis II’

Published online by Cambridge University Press:  16 September 2005

Masahiro Daimon
Affiliation:
Department of Pediatric Cardiovascular Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Masaaki Yamagishi
Affiliation:
Department of Pediatric Cardiovascular Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Rights & Permissions [Opens in a new window]

Abstract

I-cell disease is a rare, hereditary, and fatal disease, which is often complicated with disease of the cardiac valves. We have experienced a case of severe mitral valvar insufficiency in a 9-month-old male infant with I-cell disease. Mitral valvoplasty was difficult, because the leaflets were remarkably hypertrophic, and the tendinous cords were elongated and adherent. Despite these difficulties, surgery proved effective in the treatment of the congestive heart failure, allowing for further treatment of the I-cell disease.

Type
Brief Report
Copyright
© 2005 Cambridge University Press

I-cell disease, or Mucolipidosis II, is a rare inherited storage disorder of lysosomal enzymic localization. Bone marrow transplantation is the only effective treatment.1 Most of the patients, however, die of congestive heart failure, since disease of the cardiac valves is a major complicating factor.2, 3 In this report, we describe the surgical treatment of severe mitral insufficiency in a patient with I-cell disease.

Case report

An 8-month-old male infant weighing 6.4 kilograms was admitted because of tachypnea due to congestive heart failure. A diagnosis of Marfan's syndrome had been suspected after birth because of the chest deformity, arachnodactyly, scoliosis, narrowly arched palate, congenital flexion contracture, inguinal hernia, and mild mitral insufficiency. On admission, the heart rate was 142 beats per minute and regular, and a grade 3 out of 6 ejection systolic murmur was audible. The rate of respiration was 54 breaths per minute. The edge of the liver was palpable 3 fingerbreadths below the right costal margin. A chest X-ray showed cardiac enlargement. Echocardiography showed marked hypertrophy and prolapse of the mitral leaflets (Fig. 1a). Cardiac catheterization confirmed severe mitral insufficiency. When the patient was aged nine months, we planned plasty of the mitral valve to treat the recurrent heart failure. At the operation, cardiopulmonary bypass was established through a median sternotomy. The mitral valve was exposed through an incision in the right-side wall of the left atrium along the interatrial groove under cardioplegic cardiac arrest. The mitral valve had two leaflets, but both leaflets were remarkably hypertrophic, with markedly elongated and adherent tendinous cords (Fig. 1b). A cleft was seen in the aortic leaflet. We noted three papillary muscles, to which the cords were irregularly attached. We chose to shorten five of the cords, combining this with an annuloplasty that was performed at the inferomedial ends of the solitary zone of apposition between the two major leaflets performed as suggested by Reed et al.,4 and inserting a 25-millimetre Duran flexible annuloplasty ring (Medtronic, Incorporation, Minneapolis, Minnesota). Subsequent to these procedures, the water leak test showed poor ballooning of the leaflets. Thus, we took down the plasty and replaced the valve using an inversed mechanical aortic valve of 19 millimetres (ATS Medical Incorporation, Minneapolis, Minnesota). The period of extracorporeal circulation lasted 325 minutes, and the aortic cross-clamping time was 181 minutes. Paroxysmal supraventricular tachycardia was seen in the early postoperative period. postoperative respiratory management was difficult because of intractable pneumonia. Anticoagulation therapy included aspirin and ticlopidine hydrochloride. Histological examination showed a reaction to the periodic acid-Schiff stain, and toluidine blue positive mucinous deposits, in the mitral valve. The stromal cells had vacuolated cytoplasm (Fig. 2). Two weeks after the operation, cytoplasmic vacuoles were found in the lymphocytes by microscopic blood cell assessment, and further studies indicated I-cell disease. One month after the operation, echocardiographic assessment indicated normal cardiac function, and the patient was referred for transplantation of bone marrow for treatment of the I-cell disease.

Figure 1. (a) Preoperative echocardiography showing marked thickening of both leaflets of the mitral valve (arrow). LA: left atrium; LV: left ventricle. (b) Resected mitral valve showing thickening of both leaflets and adhesion of tendinous cords. AML: aortic mitral leaflet MML: mural mitral leaflet.

Figure 2. Photomicrograph of degenerative mitral valve showing mucinous deposits with swollen mononuclear cells. Hematoxylin and eosin. ×20.

Discussion

I-cell disease is an inherited, congenital, and slowly progressive disorder, and has a fatal outcome during early childhood. Its clinical manifestations are psychomotor retardation, growth failure, hypotonia, frequent respiratory infections, dysostosis multiplex, stiffness of joints and Hurler-like appearance.3, 57 The activity of serum lysosomal enzymes is high, although urinary excretion of acid mucopolysaccharides is normal. Cardiac manifestations have been reported including cardiomegaly and valvar disease.3, 6 I-cell disease is difficult to diagnose, since its manifestations resemble other disorders which also include skeletal deformity. At first, we treated the patient for Marfan's syndrome, because his physical characteristics were consistent with the diagnostic criterions. Thus, careful examination is necessary to identify I-cell disease.

To reduce the postoperative complications related to insertion of prosthetic valves, plasty is the preferred method of treatment for young patients, and early surgical results can be good.8 In our patient, we hoped to perform plasty, but it was difficult because of the marked deformities of the leaflets and tendinous cords. Specific valvar manifestations in this disease remain unknown. Valvar thickening and prolapse, nonetheless, are often seen in metabolic storage disorders.2, 3 We believe that the surgery was effective in our patient for the treatment of congestive heart failure. Thus, if heart failure is caused by valvar insufficiency, aggressive heart surgery can reduce mortality in early childhood, and thus allow for further treatment of other complicating processes, such as I-cell disease.

References

Grewal S, Shapiro E, Braunlin E, et al. Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: a long-term follow-up report. Bone Marrow Transplant 2003; 32: 957960.Google Scholar
Dangel JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders – clinical and echocardiographic findings in 64 patients. Eur J Pediatr 1998; 157: 534538.Google Scholar
Satoh Y, Sakamoto K, Fujibayashi Y, Uchiyama T, Kajiwara N, Hatano M. Cardiac involvement in mucolipidosis. Importance of non-invasive studies for detection of cardiac abnormalities. Jpn Heart J 1983; 24: 149159.Google Scholar
Reed GE, Tice DA, Clauss RH. Asymmetric exaggerated mitral annuloplasty: repair of mitral insuffciency with hemodynamic predictability. J Thorac Cardiovasc Surg 1965; 49: 752761.Google Scholar
Gilbert EF, Dawson G, Zu Rhein GM, Opitz JM, Spranger JW. I-cell disease, mucolipdosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases. Z Kinderheilkd 1973; 114: 259292.Google Scholar
Leroy JG, Spranger JW, Feingold M, Opitz JM, Crocker AC. I-cell disease: a clinical picture. J Pediatr 1971; 79: 360365.Google Scholar
Martin JJ, Leroy JG, Farriaux JP, Fontaine G, Desnick RJ, Cabello A. I-cell disease (mucolipidosis II): a report of its pathology. Acta Neuropathol (Berl) 1975; 33: 285305.Google Scholar
Zias EA, Mavroudis C, Backer CL, Kohr LM, Gotteiner NL, Rocchini AP. Surgical repair of the congenitally malformed mitral valve in infants and children. Ann Thorac Surg 1998; 66: 15511559.Google Scholar
Figure 0

(a) Preoperative echocardiography showing marked thickening of both leaflets of the mitral valve (arrow). LA: left atrium; LV: left ventricle. (b) Resected mitral valve showing thickening of both leaflets and adhesion of tendinous cords. AML: aortic mitral leaflet MML: mural mitral leaflet.

Figure 1

Photomicrograph of degenerative mitral valve showing mucinous deposits with swollen mononuclear cells. Hematoxylin and eosin. ×20.